Wire · opportunities
FDA Releases Discussion Paper on Generative AI-Enabled Medical Devices
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 27 August 2026 · Fusion42 review
The FDA's CDRH released a discussion paper proposing a new regulatory framework specifically for generative AI-enabled medical devices, including a two-axis risk assessment model and competency-based premarket evaluation, with a request for public feedback by October 19, 2026.
This Wire brief sits within Fusion42's coverage of Medtech, and 14 sources have reported it between 18 Aug 2026 and 15 Sep 2026.
◆ ◆ The Wire takeaway
You face a new FDA framework that will change how generative AI medical devices get approved, demanding precise risk and autonomy definitions in your filings. Start preparing now by defining how your device acts independently and its clinical impact to avoid delays.
◆ Coverage
14 sources · first reported 18 Aug 2026 · latest 15 Sep 2026
◆ Related on Wire
◆ Topics